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Abstract
Background: Trachomatous trichiasis can cause corneal damage and visual impairment. WHO recommends surgery for all
cases. However, in many regions surgical provision is inadequate and patients frequently decline. Self-epilation is common
and was associated with comparable outcomes to surgery in nonrandomised studies for minor trichiasis (,six lashes
touching eye). This trial investigated whether epilation is noninferior to surgery for managing minor trichiasis.
Methods and Findings: 1,300 individuals with minor trichiasis from Amhara Regional State, Ethiopia were recruited and
randomly assigned (1:1) to receive trichiasis surgery or epilation. The epilation group were given new forceps and epilation
training. The surgical group received trichiasis surgery. Participants were examined every 6 months for 2 years by clinicians
masked to allocation, with 93.5% follow-up at 24 months. The primary outcome measure (‘‘failure’’) was $five lashes
touching the eye or receiving trichiasis surgery during 24 months of follow-up, and was assessed for noninferiority with a
10% prespecified noninferiority margin. Secondary outcomes included number of lashes touching, time to failure, and
changes in visual acuity and corneal opacity. Cumulative risk of failure over 24 months was 13.2% in the epilation group
and 2.2% in the surgical group (risk difference = 11%). The 95% confidence interval (8.1%–13.9%) includes the 10%
noninferiority margin. Mean number of lashes touching the eye was greater in the epilation group than the surgery group
(at 24 months 0.95 versus 0.09, respectively; p,0.001); there was no difference in change in visual acuity or corneal opacity
between the two groups.
Conclusions: This trial was inconclusive regarding inferiority of epilation to surgery for the treatment of minor trichiasis,
relative to the prespecified margin. Epilation had a comparable effect to surgery on visual acuity and corneal outcomes. We
suggest that surgery be performed whenever possible but epilation be used for treatment of minor trichiasis patients
without access to or declining surgery.
Trial registration: http://ClinicalTrials.gov NCT00522912
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Introduction
Trachoma is the leading infectious cause of blindness worldwide
[1]. Recurrent episodes of ocular Chlamydia trachomatis infection in
early childhood provoke chronic conjunctival inflammation (active
trachoma). This inflammation can lead to conjunctival scarring,
which may cause the eyelids to roll in (entropion) and the lashes to
touch the surface of the eye (trachomatous trichiasis [TT]).
Trichiasis is probably the main risk factor for the development of
corneal opacification (CO) and visual impairment in trachoma.
However, TT encompasses a very wide spectrum of disease. At
one extreme there may be only a few metaplastic eyelashes without
entropion. At the other extreme the whole eyelid can be entropic
with all eyelashes and even the skin of the upper eyelid in contact
with the ocular surface. The risk of developing CO is related to the
severity of the trichiasis, and a distinction has been made between
minor TT (one to five lashes touching the eye) and major TT
(.five lashes touching the eye) [2–5].
Trachoma is endemic in around 50 countries, which are striving
to control the disease through the implementation of the SAFE
strategy: surgery for trichiasis, antibiotics for infection, and facial
cleanliness and environmental improvements to reduce transmis-
sion [1,6]. Currently, the World Health Organization (WHO)
recommends that all individuals with one or more trichiatic
eyelashes should be offered surgery, irrespective of lash location
(central or peripheral) or the degree of entropion. The rationale for
this recommendation is a practical one: patients with only a minor
degree of trichiasis may not be seen again for a long time and there
is a risk that the trichiasis will progress and cause visual
impairment [6]. There is broad consensus that major TT should
be treated surgically. However, for the management of minor TT
the reality is often different, with many patients and clinicians
preferring to defer surgery until the TT becomes more
problematic. In some countries, such as The Gambia, there has
been a policy of epilation (repeated removal of lashes with forceps)
for minor trichiasis and surgery for major trichiasis, which
predated the WHO guidelines [7].
In recent years the number of individuals (mainly children) with
active trachoma has declined significantly from 146 million in
1996 to 40 million in 2007, indicating that the A, F, and E
components are effective [1,8]. In contrast, the estimates of the
number of people (mainly adults) living with untreated TT have
not shown such encouraging declines: 10.6 million in 1996, 7.6
million in 2003, and 8.2 million in 2007 [1,8]. Available data
suggest that current surgical activity is probably keeping up with
incident TT but may not be clearing the backlog. For example, in
Ethiopia (the country with the most cases of TT) 1.3 million people
were estimated to have TT in 2006, but only around 300,000
operations were performed in the last 5 y [1,9].
The reasons for this treatment gap are complex and multiple.
Firstly, there may be insufficient services to address the backlog in
many regions. Many of the health workers trained in TT surgery
have been lost from programmes, may have conflicting clinical
priorities, or do not have the instruments or consumables to perform
surgery [10,11]. Secondly, services may not be accessible to patients.
Several studies have shown financial constraints, transport difficul-
ties, and lack of time to be barriers to attending for surgery [7,12–
14]. Thirdly, in many regions many patients (often the majority)
refuse the offer of surgery, even when major barriers are addressed
by the provision of free surgery at community level [7,13–15]. It is
likely that in the next 5 y at least, the overwhelming majority of
people with TT will not receive surgical treatment, irrespective of
whether the TT is minor or major.
In trachoma endemic regions, TT surgery is usually provided by
nonophthalmologists who receive about 2-wk training in one of
the WHO recommended procedures: bilamellar tarsal rotation
(BLTR) or posterior lamellar tarsal rotation (PLTR) [16,17]. Well-
conducted surgery can be a permanent solution. However,
trichiasis frequently recurs after surgery, particularly under
operational conditions (as compared to clinical trials) where rates
as high as 60% recurrence have been reported [3,18–20].
Currently limited longitudinal data are available on which to
base recommendations for individuals with minor TT. One cohort
study of individuals with TT who refused surgery found that over a
4-y period, 37% progressed from minor to major TT and 5.1%
developed new corneal opacity [4]. In a parallel cohort of patients
from the same area who had accepted TT surgery, the
comparable risks were 41% and 5.2%, respectively [18]. A second
longitudinal study also found no difference in risk of developing
new corneal opacity between people receiving TT surgery and
those declining it, over a 1-y period [21]. Studies from several
trachoma endemic regions suggest that the majority of people with
TT epilate [7,22]. Two cross-sectional studies have found that
epilation is associated with a reduced risk of corneal opacity [2,23].
In high-income settings patients with a minor degree of trichiasis,
such as metaplastic or misdirected lashes caused by lid margin
disease, are often managed by repeated epilation. Epilation is
simple for a trained helper to perform. However, it is an ongoing
treatment that needs to be repeated when eyelashes regrow and
should be conducted using good quality forceps.
In view of the prevalence of unoperated TT, the limited
capacity of current surgical services, concerns over programmatic
surgical outcomes, and the high rates of refusal, epilation might be
an acceptable alternative to surgery for the management of minor
TT. In this randomised trial we tested the hypothesis that epilation
is noninferior to surgery for the treatment of minor TT.
Methods
Ethics Statement
The National Health Research Ethics Review Committee of the
Ethiopian Ministry of Science and Technology, the London
School of Hygiene and Tropical Medicine Ethics Committee, and
Emory University Institutional Review Board approved the trial.
Potential participants were provided with both written and oral
information in Amharic about the trial. For those agreeing to
participate, written informed consent in Amharic was required
prior to enrolment. If the participant was unable to read and write,
the information sheet and consent form were read to them and
their consent recoded by witnessed thumbprint. An independent
Data Safety Monitoring Committee reviewed the trial for patient
safety and there were no deviations from the original protocol. No
interim analyses for efficacy or futility were planned or conducted.
The trial protocol is described in Text S1 and the CONSORT
statement in Text S2.
Participants
Eligible participants were individuals aged 18 y or over with
previously unoperated minor trichiasis (,six trichiatic eyelashes,
some of which may have been epilated and were regrowing) who
presented during a TT treatment campaign in rural villages in West
Gojjam, Amhara Region, Ethiopia from March to June 2008.
Exclusion criteria were previous eyelid surgery, medically unfit, or
pregnancy (self-reported or clearly evident). The campaigns were
advertised in local markets, churches, and schools. Additionally,
health extension workers from the subdistricts (kebele) in the study
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area were trained to recognize trichiasis and visited each village in
their kebele to identify patients. In individuals with bilateral TT, only
one eye was randomly designated as the study eye and included in
the analysis, although both eyes were treated.
Baseline Clinical Assessment
The clinical assessments and surgery were performed in
government health centres. A field worker administered a
questionnaire in Amharic. Height and weight were measured.
Unaided and pinhole LogMAR visual acuities were measured at
4 m, using an ETDRS equivalent Tumbling-E LogMAR chart
(Hong Kong Low Vision Centre). The testing distance was
reduced to 2 or 1 m if necessary. For those unable to read the
LogMAR chart at 1 m their visual acuity was tested by counting
fingers at 1 m or hand movements at 0.5 m. For visual acuities of
counting fingers or less, LogMAR values were attributed: counting
fingers, 2.0; hand movements, 2.5; perception of light, 3.0; no
perception of light, 3.5. No patients had spectacles for distance
correction. In this report we present only unaided visual acuities.
Ophthalmic examinations were conducted in a darkened room
using 2.56 magnification loupes and a bright torch. A single
ophthalmologist (SNR) performed all baseline examinations. The
number of lashes touching the eye was counted (‘‘lash burden’’)
and also subdivided by the part of the eye contacted when looking
straight ahead: cornea, lateral conjunctiva, or medial conjunctiva.
Clinical evidence of epilation was identified by the presence of
broken or newly growing lashes, or areas of absent lashes. Upper
lid entropion was graded by assessing the degree of inward
rotation of the eyelid margin (Table S1). The degree of
conjunctivilisation of the lid margin (anteroplacement of the
muco-cutaneous junction) was assessed (Table S1). The degree of
corneal scarring was classified using a modified WHO detailed
trachoma grading system (FPC) in which the degree of central
corneal scarring (CC2) was subdivided into four, to provide more
definition (Table S1) [24]. The Simplified WHO Trachoma
Grading System corneal opacity measure (CO) is equivalent to
CC2 and CC3 [25]. Tarsal conjunctival papillary inflammation,
follicles, and scarring were classified using the WHO FPC grading
system [24]. Standardised high-resolution digital photographs
were taken of each of these features.
Interventions
Following the baseline clinical assessment, participants were
randomised to one of two intervention groups: surgery or
epilation. The posterior lamella tarsal rotation procedure was
used in all surgery cases [17]. Surgery was performed under local
anaesthesia administered by subcutaneous infiltration of the upper
eyelid: 2–3 ml of lidocaine 1%, with adrenaline. The lid was then
everted and the posterior lamella (tarsal conjunctiva and tarsal
plate) incised parallel to and 3 to 4 mm above the lid margin. The
posterior and anterior (obicularis oculi and skin) lamellae were
separated by blunt dissection. Three sets of 4/0 silk everting
sutures (three-eighth circle, 16-mm cutting needles, Mersilk,
Ethicon) were placed to externally rotate the lower border of the
eyelid. Postoperatively, the operated eye was padded until the next
morning and tetracycline eye ointment was self-administered twice
a day for 2 wk. Five nurses, who had previously been trained in
and were regularly performing TT surgery, performed the surgery
in this trial. They were identified as the best surgeons from a larger
group of nine during a 2-d standardisation workshop. This
training was conducted by an experienced Ethiopian ophthalmol-
ogist (ABK), who had contributed to the development of the
WHO TT surgeon certification manual [17]. The posterior
lamellar tarsal rotation techniques of the five nurses were carefully
observed and standardised to ensure that all performed the
operation in the same way. The intraoperative quality of surgery
was periodically reviewed during the course of the trial.
Individuals randomised to the epilation group were each given
two pairs of high quality, machine-manufactured epilation forceps
with round edged tips (for corneal safety) and flat, opposing plates
to improve grip and reduce the likelihood of breaking lashes
(Tweezerman). The patient and an accompanying adult (‘‘epila-
tor’’) with good near vision were trained to perform epilation.
They observed the trainer epilate one or two lashes, with
particular attention paid to removing the lash at its base to
minimise broken stubs. The epilator was then observed epilating
lashes and given advice on technique.
Follow-up Clinical Assessments
All participants in the surgery arm were seen 7–10 d
postoperatively, at which point the sutures were removed and
any complications noted and treated as needed. Several different
ophthalmic nurses who did not take part in subsequent follow-ups
conducted the 7–10-d suture removal follow-up. Follow-up
assessments were conducted for both groups at 6, 12, 18, and
24 mo. On each occasion an ophthalmic examination was
performed and digital photographs taken. Visual acuity was
measured at 12 and 24 mo. The preoperative, 12-mo, and 24-mo
examinations were conducted by a single ophthalmologist (SNR)
and the 6- and 18-mo were conducted by a single ophthalmic
nurse (EH). Neither of these examiners was involved in performing
treatments in this trial. The examiners were standardised to each
other and showed strong agreement between these two observers
for the presence of trichiasis in a preliminary assessment of 200
eyes (kappa= 0.86). The presence/absence of notching (overcor-
rection of the central portion of the lid) and conjunctival
granuloma were noted.
Any individual who showed evidence of disease progression,
defined as five or more trichiatic lashes or corneal changes related
to observed lashes at any follow-up examination, was immediately
offered surgery (epilation arm) or repeat surgery (surgery arm) to
be performed by a senior surgeon. These individuals continued to
be followed up according to the trial protocol. Individuals in
whom other ophthalmic pathology (e.g., cataract) was detected
were referred to the regional ophthalmic services. New epilating
forceps were provided as required. At the final follow-up (24 mo),
all participants in the epilation arm were offered TT surgery.
Outcome Measures
The primary outcome measure was the proportion of
individuals at any follow-up who had ‘‘failed,’’ defined as either
(1) five or more eyelashes touching the globe or (2) a history of
surgery performed in the trial eye at any point during the follow-
up period (in the case of the surgical arm this would be repeat
surgery). The five or more lash threshold for failure was chosen to
make it slightly more stringent than the inclusion criteria. A priori
defined secondary outcome measures at 12- and 24-mo were: CO,
visual acuity, entropion, conjunctival inflammation and symptoms
of pain, subjective visual acuity, epiphora, and dryness.
Change in CO was assessed both by direct comparison of the 1-
and 2-y photographs with the baseline photograph, and by
comparison of the field grading scores. Photographs for each time
point were viewed on a computer screen at about 106
magnification by a single masked observer (MJB). They were first
graded using the trial grading system (Table S1). Then the 1- and
2-y images were compared side by side with the baseline image,
allowing the direct comparison of opacities to assess whether they
had changed; these were graded as improved, no change, or
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worse. The baseline photographic and field CO scores showed
good correlation (linear weighted kappa score 0.74; quadratic
weighted kappa score 0.87).
Randomisation, Allocation Concealment, and Masking
Participants were randomly allocated to the epilation or surgery
groups using a 1:1 allocation ratio for each surgeon, using a
computer-generated randomisation sequence with random block
sizes. Randomisation was stratified by surgeon because of possible
intersurgeon variability (each surgeon had a separate sequence).
The London-based statistician held the master randomisation lists.
The random allocation sequences for each surgeon were
concealed in sequentially numbered, sealed, opaque envelopes,
which were colour coded for surgeon and placed in separate
containers for each surgeon. The person who prepared these
envelopes was independent of all other aspects of the trial.
Following the baseline examination, participants were allocated to
the next available surgeon. A field worker was responsible for
implementing the intervention assignment in a dedicated area,
separated from those performing the preoperative examinations.
The two individuals (SNR, EH) responsible for all the clinical
outcome measurements were masked to the allocation. At follow-
up, the trichiasis and corneal examination was performed and
recorded before the eyelid was everted, so that the examiner was
masked to whether surgery had been performed on the tarsal
conjunctiva. The posterior lamella tarsal rotation technique used
in this study does not involve a skin incision, so there were no
external marks of previous surgery that could unmark the
observer.
Statistical Methods
A noninferiority trial design was chosen to investigate epilation
in the management of minor trichiasis because of the potential
secondary benefits of this intervention (greater acceptability and
availability). Epilation is an ongoing treatment, which is performed
when a trichiatic lash regrows. As such it is intrinsically less likely
to be effective than surgery at always preventing lashes from
touching the eye. In a noninferiority trial a slightly reduced clinical
efficacy might be accepted if this is balanced by other secondary
benefits; in the case of epilation these include greater acceptability
and availability in an endemic population compared to surgery.
We chose a noninferiority margin (D) of 10% at the outset of this
trial as we considered this level to balance the considerations of
clinical efficacy and secondary benefits.
The sample of 1,300 trial participants provided 90% power to
detect noninferiority based on a two-sided 95% CI approach,
assuming a 10% loss to follow-up over 2 y, a 5% failure rate in the
surgery group, and a D of 10% between the epilation and surgery
groups respectively [3,26].
Data were double-entered into an Access (Microsoft) database
and transferred to Stata 11 (StataCorp). Data were analysed by
intention to treat. For participants who had bilateral treatment
only the randomly designated ‘‘study eye’’ was included in the
analysis. Patients were excluded from a specific analysis if they had
missing data relevant to that analysis, as indicated in the results.
Missing data were not imputed.
The 95% CI for the difference in the proportion of ‘‘failures’’
(proportion having$five lashes touching the eye or having surgery
during follow-up period) between the two groups was estimated
using exact methods. The primary outcome and binary secondary
outcomes were compared between the two groups using logistic
regression analyses to estimate the odds ratio (OR) and 95% CI.
Time to failure was analysed with Kaplan-Meier survival curves,
and Cox regression models to estimate hazard ratios (HRs) and
95% CI. Individuals who had reached endpoint at a previous time
point or were permanently lost to follow-up from that time
onwards were censored. The number of lashes touching the eye
was analysed using zero-inflated Poisson regression to allow for the
high proportion of eyes with no lashes touching [27]. The signed-
rank test was used to analyse the difference in the number of lashes
touching the eye between baseline and 24-mo follow-up. Changes
in LogMAR visual acuity score were analysed by logistic
regression. A multivariable logistic regression model was used to
assess associations of failure with potential explanatory factors.
Variables that were associated with the outcome on univariable
analyses (p,0.2) were retained in the multivariable model. For
participants in the surgery arm, the cumulative risk of adverse
surgical outcomes was estimated, including recurrence ($one
lashes touching the eye or clinical evidence of epilation),
granuloma, and lid notching.
Results
Participant Recruitment and Flow
Trial participants were recruited between March and June
2008. Several thousand people presented with eye complaints
during the course of the surgical outreach campaign and were
assessed for eligibility for this trial. The majority had other
ophthalmic conditions such as cataract. A total of 1,300
consecutive eligible individuals were identified, all of whom
consented to participate, were randomised, and received their
allocated treatment (650 participants per group) (Figure 1).
Primary outcome data are available for 637/650 (98.0%)
participants in the epilation group and 641/650 (98.6%)
participants in the surgery group (Figure 1). Overall, 84.1% of
participants were seen at all five scheduled visits over 24 mo: 517/
650 (79.5%) in the epilation group and 576/650 (88.6%) in the
surgery group. There were slightly fewer follow-up examinations
in the epilation group (2,374/2,600 [91.3%]) compared with the
surgery group (2,467/2,600 [94.9%], p,0.001). 22 participants
were not seen after baseline (13 epilation group, nine surgery
group, p=0.39).
Baseline Demographic and Clinical Characteristics
All participants were Ethiopians of Amharan ethnicity. Their
mean age was 50.3 y and the majority (66.4%) were female.
Baseline sociodemographic characteristics were generally balanced
by randomisation group, although there were slightly fewer female
participants in the epilation group than the surgery group (63.9%
versus 68.9%) (Table 1). Clinical features were also balanced
(Table 1) with the exception of central corneal opacity (CC2/CC3
or CO), which was more frequent in the epilation group (175;
26.9%) than the surgery group (137; 21.1%) at baseline.
Primary Outcome
Overall, 98 individuals developed the primary outcome: 84
(13.2%) in the epilation group and 14 (2.2%) in the surgery
group. In the epilation arm 74 had $five lashes and an additional
ten participants had received repeat surgery elsewhere; in the
surgery arm four had $five lashes and a further ten had received
repeat surgery elsewhere. The difference in cumulative risk of
failure was 11.0% (95% CI 8.1%–13.9%). The 95% CI includes
the prestated margin of inferiority (D, 10.0%), so the trial is
inconclusive and does not show evidence of noninferiority of
epilation versus surgery, with respect to this prespecified
noninferiority margin.
The rate of failure was greater in the epilation group (hazard
ratio [HR]= 6.38, 95% CI 3.62–11.23) (Figure 2). The mean
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number of lashes touching the eye at each visit was small (Table 2),
but was significantly greater in the epilation group (p,0.001). The
number of lashes touching the eye reduced significantly between
baseline and 24 mo in both groups (p,0.001). Among patients in
the epilation group, successful epilation (no lashes touching) at
baseline was associated with reduced risk of failure (adjusted
OR=0.33, 95% CI 0.13–0.86) and baseline entropion of greater
than grade 1 was associated with increased risk (adjusted
OR=1.72, 95% CI 0.98–3.02) (Table 3). There were too few
failures in the surgery group to model.
Visual Acuity
There was no evidence of a difference in change in visual acuity
(Table 2) from baseline to follow-up between the two groups at
either 12 mo (OR=1.17, 95% CI 0.87–1.59) or 24 mo
(OR=1.16, 95% CI 0.88–1.53). There was similarly no evidence
Figure 1. Trial profile.
doi:10.1371/journal.pmed.1001136.g001
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Table 1. Baseline demographic and clinical characteristics of participants in each arm of the trial.
Characteristic Surgery, n=650 Epilation, n=650
n Percent or 95% CI n Percent or 95% CI
Gender (female) 448 (68.9%) 415 (63.9%)
Age (y)
18–30 69 (10.6%) 67 (10.3%)
30–39 113 (17.4%) 108 (16.6%)
40–49 156 (24.0%) 150 (23.1%)
50–59 160 (24.6%) 158 (24.3%)
60–69 112 (17.2%) 122 (18.8%)
70+ 40 (6.2%) 45 (6.9%)
Mean (SD, 95% CI) 49.9 (14.4, 48.8–51.0) 50.7 (14.5, 49.6–51.8)
Illiterate 581 (89.4%) 588 (90.5)
BMI, mean (SD, 95% CI) 19.9 (2.3, 19.7–20.1) 20.0 (2.4, 19.8–20.2)
Study eye (right)a 319 (49.1%) 302 (46.5%)
Best corrected LogMAR VA in study eye
20.2 to 0.3 243 (37.7%) 211 (32.5%)
0.3–0.7 261 (40.5%) 264 (40.7%)
0.7–1.1 83 (12.9%) 89 (13.7%)
1.1–2.0 19 (3.0%) 28 (4.3%)
CF/HM/PL 30 (4.7%) 51 (7.9%)
NPL 9 (1.4%) 6 (0.9%)
Not measurableb 5 (0.8%) 1 (0.2%)
Entropion grade
0 276 (42.5%) 292 (44.9%)
1 258 (39.7%) 254 (39.1%)
2 113 (17.4%) 102 (15.7%)
3 3 (0.5%) 2 (0.3%)
4 0 (0.0%) 0 (0.0%)
Trichiasis (number of lashes touching eye)
Mean (95% CI) 1.52 (1.43–1.62) 1.62 (1.52–1.72)
None, epilating 124 (19.1%) 113 (17.4%)
1–5 lashes 526 (80.9%) 537 (82.6%)
Trichiasis position
Corneal 6 peripheral 462 (71.1%) 470 (72.3%)
Peripheral only 188 (28.9%) 180 (27.7%)
Lower lid TT (present) 70 (10.8%) 57 (8.8%)
Corneal opacity – field grading
CC0, none 345 (53.1%) 330 (50.8%)
CC1, peripheral 168 (25.9%) 145 (22.3%)
CC2a, off centre faint 76 (11.7%) 97 (14.9%)
CC2b, off centre dense 9 (1.4%) 15 (2.3%)
CC2c, central faint 30 (4.6%) 43 (6.6%)
CC2d, central dense 11 (1.7%) 14 (2.2%)
CC3, total central dense 10 (1.5%) 4 (0.6%)
CC4, phthisis 1 (0.2%) 2 (0.3%)
CO or CC2/CC3 137 (21.1%) 175 (26.9%)
Papillary inflammation
None (P0) 52 (8.0%) 66 (10.2%)
Mild (P1) 248 (38.2%) 248 (38.1%)
Moderate (P2) 297 (45.7%) 282 (43.4%)
Severe (P3) 53 (8.1%) 54 (8.3%)
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Characteristic Surgery, n=650 Epilation, n=650
n Percent or 95% CI n Percent or 95% CI
Conjunctival scarring
None (C0) 3 (0.5%) 4 (0.6%)
Mild (C1) 60 (9.2%) 52 (8.0%)
Moderate (C2) 508 (78.2%) 520 (80.0%)
Severe (C3) 79 (12.2%) 74 (11.4%)
Conjunctivilisation grade
0 7 (1.1%) 5 (0.8%)
1 18 (2.8%) 25 (3.9%)
2 165 (25.4%) 146 (22.5%)
3 460 (70.8%) 474 (72.9%)
Lagophthalmos (present) 10 (1.5%) 9 (1.4%)
n follow-up assessments
0 9 (1.4%) 13 (2.0%)
1 10 (1.5%) 13 (2.0%)
2 12 (1.9%) 28 (4.3%)
3 43 (6.6%) 79 (12.2%)
4 576 (88.6%) 517 (79.5%)
aParticipants with bilateral TT had one eye randomly selected as the trial eye.
bUnable to cooperate with visual acuity measurement.
BMI, body mass index; CF, count fingers; HM, hand movements; PL, perception of light; NPL, no perception of light; SD, standard deviation; VA, visual acuity.
doi:10.1371/journal.pmed.1001136.t001
Table 1. Cont.
Figure 2. Kaplan Meier graph of time to failure.
doi:10.1371/journal.pmed.1001136.g002
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Table 2. Clinical characteristics of participants in each arm of the trial at 12 and 24 mo.
Characteristic 12 mo 24 mo
Surgery, n=620 Epilation, n=598 Surgery, n=613 Epilation, n=603
Trichiasis - mean n lashes touching eye (95% CI) 0.11 (0.07–0.14) 1.00 (0.89–1.11) 0.09 (0.06–0.12) 0.95 (0.84–1.06)
Best corrected LogMAR VA in trial eye
20.2 to 0.3 225 (36.4%) 189 (31.8%) 200 (32.7%) 167 (27.8%)
0.3–0.7 261 (42.2%) 231 (38.8%) 272 (44.4%) 258 (43.0%)
0.7–1.1 72 (11.6%) 95 (16.0%) 79 (12.9%) 93 (15.5%)
1.1–2.0 26 (4.2%) 33 (5.6%) 25 (4.1%) 34 (5.7%)
CF/HM/PL 30 (4.9%) 37 (6.2%) 28 (4.6%) 40 (6.7%)
NPL 5 (0.8%) 10 (1.7%) 8 (1.3%) 8 (1.3%)
LogMAR change (baseline to follow-up)
.0.3 worse 49 (8.0%) 66 (11.1%) 71 (11.7%) 87 (14.5%)
0.1–0.3 worse 119 (19.3%) 108 (18.2%) 136 (22.4%) 137 (22.9%)
Within 0.1 (same) 308 (50.0%) 293 (49.3%) 277 (45.6%) 261 (43.6%)
0.1–0.3 better 97 (15.8%) 97 (16.3%) 85 (14.0%) 75 (12.5%)
.0.3 better 43 (7.0%) 30 (5.1%) 38 (6.3%) 39 (6.5%)
Entropion grade
0 598 (96.5%) 223 (37.3%) 588 (95.9%) 167 (27.7%)
1 19 (3.1%) 219 (36.6%) 18 (2.9%) 162 (26.9%)
2 3 (0.5%) 154 (25.8%) 7 (1.1%) 272 (45.1%)
3 0 (0.0%) 2 (0.3%) 0 (0.0%) 2 (0.3%)
4 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Corneal opacity – field grading
CC0, none 344 (55.5%) 275 (46.0%) 354 (57.8%) 290 (48.1%)
CC1, peripheral 151 (24.4%) 147 (24.6%) 136 (22.2%) 140 (23.2%)
CC2a, off centre faint 70 (11.3%) 102 (17.1%) 67 (10.9%) 98 (16.3%)
CC2b, off centre dense 14 (2.3%) 18 (3.0%) 15 (2.5%) 25 (4.2%)
CC2c, central faint 22 (3.6%) 35 (5.9%) 18 (2.9%) 28 (4.6%)
CC2d, central dense 12 (1.9%) 16 (2.7%) 15 (2.5%) 14 (2.3%)
CC3, total central dense 6 (1.0%) 2 (0.3%) 7 (1.1%) 5 (0.8%)
CC4, phthisis 1 (0.2%) 3 (0.5%) 1 (0.2%) 3 (0.5%)
Corneal opacity change, baseline to
follow-up – photographic grading
More corneal opacity 7 (1.1%) 12 (2.0%) 25 (4.1%) 33 (5.5%)
No change 602 (97.3%) 575 (96.8%) 579 94.6%) 561 (93.3%)
Less corneal opacity 10 (1.6%) 7 (1.2%) 8 (1.3%) 7 (1.2%)
Corneal opacity change, baseline to
follow-up – field grading
.3 grades worse 1 (0.2%) 2 (0.3%) 1 (0.2%) 1 (0.2%)
3 grades worse 0 (0.0%) 0 (0.0%) 1 (0.2%) 1 (0.2%)
2 grades worse 17 (2.9%) 27 (4.5%) 18 (2.9%) 22 (3.7%)
1 grade worse 61 (9.8%) 75 (12.5%) 44 (7.2%) 77 (12.8%)
No change 452 (72.9%) 418 (69.9%) 457 (74.6%) 436 (72.3%)
1 grade better 72 (11.6%) 50 (8.4%) 71 (11.6%) 44 (7.3%)
2 grades better 16 (2.6%) 23 (3.9%) 19 (3.1%) 19 (3.2%)
3 grades better 1 (0.2%) 3 (0.5%) 1 (0.2%) 3 (0.5%)
.3 grades better 0 (0.0%) 0 (0.0%) 1 (0.2%) 0 (0.0%)
Papillary inflammation
None (P0) 172 (27.7%) 137 (22.9%) 328 (53.5%) 269 (44.6%)
Mild (P1) 279 (45.0%) 251 (42.0%) 130 (21.2%) 130 (21.6%)
Moderate (P2) 163 (26.3%) 191 (31.9%) 147 (24.0%) 186 (30.9%)
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of a difference within randomisation group between the baseline
and 24-mo visual acuity (paired t-test: surgery group p=0.88;
epilation group p=0.99).
Corneal Opacification
Photograph comparison. There was little change in CO,
and no significant differences between the two groups.
Comparison of the baseline and 24-mo follow-up corneal
photographs found incident or progressive corneal opacity in 58
eyes (5.5% epilation; 4.1% surgery; p=0.25).
Field grading. Comparison of baseline with follow-up field
scores found moderate variation within both groups. The majority
of patients in each arm had no change and most differences were of
one grade (Table 2). There was a significant difference in change in
CO between baseline and 24 mo, with a greater proportion of
patients in the epilation arm having progression between baseline
and 24 mo (16.8% epilation; 10.4% surgery; p=0.001). However,
using the detailed WHO FPC trachoma grading system for the
analysis of the field scores there was no statistically significant
difference between the two groups in the proportion of eyes with
incident or progressive central CO between baseline and 24 mo
(6.5% epilation; 4.7% surgery; p=0.19).
Surgical Outcomes
Trichiasis recurred (defined as one or more lashes touching the
eye, or repeat surgery by another provider) in 114 (17.5%)
individuals in the surgery group by 24 mo: 103 had minor TT
recurrence, five had major TT recurrence, and six had repeat
surgery from another provider. For comparison, in the epilation
arm at 24 mo 298 (49.4%) had one or more lashes touching the
eye. Surgery was associated with a marked reduction in entropion
grade at 24 mo (4% versus 72% entropion grade $1; OR=0.02,
95% CI 0.01–0.25) and lid margin conjunctivilisation grade at
24 mo (78% versus 98% conjunctivilisation grade $2; OR=0.05,
95% CI 0.03–0.06) when compared to epilation. Adverse
outcomes in the surgery arm are presented in Table 4.
Symptoms
Participants were asked about their symptoms (Table 5). At
12 mo postrandomisation, participants in the surgery arm recalled
greater treatment pain than those in the epilation group (p,0.001)
but reported better subjective improvement in vision (p,0.001)
and less eye-watering (p,0.001).
Management at 24 Months
At 24 mo postrandomisation, 593/603 individuals in the
epilation group had not had surgical treatment of their trichiasis.
When offered free surgery, 185/593 (31%) accepted.
Discussion
We found no evidence that epilation is noninferior to surgery for
the management of minor trichiasis, using a noninferiority margin
of 10% for the difference in cumulative risk of failure. Therefore,
in statistical terms, the trial is inconclusive. The proportion failing
was 13.2% in the epilation group and 2.2% in the surgical group
(difference = 11.0%; 95% CI 8.1%–13.8%). A relatively small
proportion of patients in the epilation arm had evidence of
progressive trichiasis; the rate of progression was slower than those
Characteristic 12 mo 24 mo
Surgery, n=620 Epilation, n=598 Surgery, n=613 Epilation, n=603
Severe (P3) 6 (1.0%) 19 (3.2%) 8 (1.3%) 18 (3.0%)
Conjunctivilisation grade
0 115 (18.6%) 7 (1.2%) 4 (12.1%) 5 (0.8%)
1 88 (14.2%) 9 (1.5%) 63 (10.3%) 6 (1.0%)
2 258 (41.6%) 83 (13.9%) 309 (50.4%) 54 (9.0%)
3 159 (25.7%) 499 (83.4%) 167 (27.2%) 537 (89.2%)
Lagophthalmos (present) 9 (1.45%) 11 (1.8%) 2 (0.3%) 1 (0.2%)
CF, count fingers; HM, hand movements; PL, perception of light; NPL, no perception of light; VA, visual acuity.
doi:10.1371/journal.pmed.1001136.t002
Table 2. Cont.
Table 3. Univariable and multivariable associations for
reaching endpoint in the epilation group.
Variable OR 95% CI p-Value
Univariable analysis
No lashes at baseline (successful epilation) 0.27 0.11–0.68 0.005
Entropion (.grade 1) at baseline 1.75 1.08–2.83 0.02
Conjunctivalisationa 1.51 0.97–2.33 0.07
Conjunctival bacteria at baseline 1.00 0.51–1.98 0.99
Persistent inflammation (grade 3+ for 3+
examinations)
1.70 1.08–2.67 0.02
Female 0.96 0.60–1.55 0.88
Age,30 y 2.38 1.28–4.40 0.006
Literate 1.52 0.76–3.05 0.24
BMI,18 1.48 0.86–2.54 0.15
Multivariable logistic regression model
No lashes at baseline (successful epilation) 0.33 0.13–0.86 0.02
Entropion (.grade 1) at baseline 1.72 0.98–3.02 0.06
Conjunctivalisation 1.68 0.94–3.00 0.08
Persistent inflammation (grade 3+ for 3+
examinations)
1.52 0.90–2.57 0.12
Age,30 y 2.00 0.91–4.39 0.09
BMI,18 1.47 0.79–2.75 0.22
aLikelihood ratio test, no evidence of nonlinearity. Therefore combined measure
of conjunctivilisation used in logistic regression model.
BMI, body mass index.
doi:10.1371/journal.pmed.1001136.t003
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previously reported [4,21]. Failure in the epilation arm was less
frequent when the subject had been successfully epilating prior to
enrolment and was more frequent if moderate entropion was
present.
Overall, there was no significant difference in change in visual
acuity between the groups. However, following surgery more
people subjectively felt their vision had improved compared to
those in the epilation group. This difference may have been due to
watering of the eye (epiphora), which was reported more
frequently by the epilation group, or disturbance caused by
residual lashes. However, there could have also been an element of
reporter bias, as participants who have received surgery may have
felt more obliged to report an improvement to the team that
provided the surgery. There was no significant change in vision
over 2 y within either group. Two previous studies have reported a
modest short-term improvement in visual acuity following surgery;
however, both studies included many patients with more severe
trichiasis; these people probably have greater potential for visual
improvement [3,28].
Direct comparison of the baseline with 1- and 2-y corneal
photographs found that there was very little change in corneal
appearance and that there was no difference between the groups.
The comparison of the longitudinal field grading scores suggested
more variation occurred in both groups between time points, with
slightly more progression in the epilation arm compared to the
surgery arm. When the field scores were analysed using the WHO
FPC grading system, there was no significant difference in
progression between the groups. Our results are consistent with
two previous longitudinal nonrandomised studies that examined
corneal change in individuals with minor trichiasis, which found
no difference in the development of new CO between those
accepting surgery and those declining it (who were mostly
epilating) [4,18,21].
Overall, the authors consider that direct comparison of high-
resolution digital photographs viewed at high magnification offers
the most reliable measure of change in corneal appearance. Whilst
it is possible that photographs are slightly less sensitive than careful
direct clinical examination for very faint haze (which would not
normally be considered trachomatous CO), it is unlikely that
visually significant lesions would be missed. The kappa scores for
the comparison of the field and photographic grading indicated
good agreement between the observers. However, when a very
detailed grading system such as the one developed for this study is
used, some changes will lie at the boundary between two grades;
even when all observations are performed by the same
experienced ophthalmologist it is inevitable that some (unchanged)
lesions will be graded slightly differently on different occasions,
which we think accounts for much of the change reported by field
scores. Of note, the two groups were not balanced at baseline for
the amount of central corneal opacity (CO or CC2/CC3); by
chance there was significantly more CO in those randomised to
the epilation group, which may have led to more ‘‘observation
noise’’ occurring in this group. This ‘‘observation noise’’ can be
overcome by direct comparison of photographs, and explains why
overall much less change was observed between the photographs.
Photographs also offer the opportunity to detect change in lesions
that may not result in a change in the categorical grade, so in this
respect they are more sensitive than the categorical field grading.
Table 5. Symptoms reported by participants at 12- and 24-mo follow-ups.
Characteristic 12 mo 24 mo
Surgery, n=620 Epilation, n=598 Surgery, n=613 Epilation, n=603
Vision
Better 484 (78.2%) 200 (33.4%) 545 (88.9%) 153 (25.4%)
Same 87 (14.0%) 297 (49.7%) 59 (9.6%) 446 (74.1%)
Worse 48 (7.8%) 101 (16.9%) 9 (1.5%) 3 (0.5%)
Eye pain 272 (44.0%) 417 (69.7%) 353 (57.6%) 498 (82.6%)
Eye watering 318 (51.4%) 378 (63.2%) 366 (59.7%) 423 (70.2%)
Dry eye 138 (22.3%) 162 (27.1%) 134 (21.9%) 167 (27.7%)
Treatment paina
None 49 (8.0%) 167 (33.3%) — —
Mild 274 (44.8%) 193 (38.5%) — —
Moderate 17 (2.8%) 6 (1.2%) — —
Severe 262 (42.8%) 136 (27.1%) — —
Don’t remember 10 (1.6%) 0 (0.0%) — —
aAs recalled at 12 mo.
doi:10.1371/journal.pmed.1001136.t005
Table 4. Postsurgical complications (a) at 7–10-d follow-up
and (b) at any subsequent follow-up.
Outcome n Individuals
(a) Early postoperative (7–10 d) complications
Undercorrection (lashes touching or nearly touching globe) 5 (0.8%)
Overcorrection 2 (0.3%)
Infection/red eye 3 (0.5%)
Infection and undercorrection 1 (0.2%)
Bleeding 3 (0.5%)
(b) Complications during 2-y follow-up
Recurrence 105 (16.2%)
Granuloma 18 (2.9%)
Notching 29 (4.7%)
doi:10.1371/journal.pmed.1001136.t004
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Surgery, when there is no recurrence, offers a potentially long-
lasting solution, whilst epilation is an ongoing intervention, which
needs to be repeated when trichiatic lashes regrow. Therefore, it is
to be expected that surgery would be better at preventing any
eyelashes from touching the eye. However, surgery is not without
problems. Although few individuals in the surgery arm reached
endpoint, 16% developed recurrent TT. This number is slightly
lower than that generally reported in trials and case series and is
probably due to the relatively mild stage of the disease in the
people recruited compared to other studies and the extra training
and high surgical volume of the surgeons participating in this study
[3,18–20]. Lid margin notching, which is cosmetically unsatisfac-
tory, was found in 5% of participants in the surgery arm and
conjunctival granulomas requiring an additional minor procedure
in 3%.
There are several considerations in interpreting the results of
this trial. The choice of D in noninferiority trials is inevitably open
to debate. In selecting a noninferiority margin of 10%, we took a
relatively conservative view as to what would be programmatically
acceptable, given the secondary benefits of acceptability and
availability of epilation. If one were to only consider the clinical
outcome in evaluating whether there is a place for epilation in the
management of mild trichiasis, one would reject it, as the data
from this study indicate that surgery is better at preventing lashes
touching the eye. However, it should be borne in mind that the
surgery in this trial was performed by surgeons selected for the
high quality of their operating ability; they received refresher
training and were routinely operating large numbers of cases. It is
likely that the results they achieved were better than those that
might be obtained under standard conditions. Therefore, under
operational conditions the difference in clinical outcome between
surgery and epilation would probably be smaller.
Moreover, the reality on the ground is that a large majority of
the approximately 8 million people who have TT are not receiving
surgical treatment. Given the enormous backlog of untreated cases
and slow progress in addressing this, surgery is unlikely to be
available to very large numbers of people living with trichiasis for
at least the medium term. This situation is due to multiple
challenges including insufficient numbers of health workers trained
in TT surgery, who generally have conflicting responsibilities,
limited resources, and barriers to accessing surgery such as low
awareness of services and nonfinancial costs such as the time off
work recuperating [10,11]. Some of these challenges can and will
be overcome with improved service organisation and investment.
However, despite huge efforts to scale up trichiasis surgery
services, for many patients the surgical services are likely to
remain unavailable, inaccessible, or prohibitively expensive for the
medium term [7,12–14]. Furthermore, many patients, particularly
those with mild disease, decline the offer of surgery, even where
this is being provided free of charge at community level, preferring
to epilate [7,13–15]. Of note at the close of this trial all individuals
in the epilation group were offered free, community-based surgery;
only 31% accepted. Epilation is cheap, can be provided
immediately during the first encounter of the patient with the
service, delivered by volunteers with minimal training at
community level to large numbers of people, and is generally
acceptable to patients as a treatment modality.
Whether there is a role for epilation in trachoma control is
ultimately a decision for individual national programmes, which
would need to take into account a number of locally specific
factors including the availability of staff and resources to provide a
high quality surgical service and the acceptability of surgery to the
population they serve.
There are several limitations to this study. Differential loss to
follow-up is a potential source of bias in noninferiority trials, as one
arm might have fewer opportunities to demonstrate failure. There
were slightly fewer follow-up assessments in the epilation arm;
however, this difference was not great and would be unlikely to
have materially affected the trial outcome. There was a very slight
difference between the two arms of the trial in the proportion that
are female and, as discussed above, in the baseline prevalence of
CO. These slight differences occurred by chance, as there were no
errors in randomisation allocation. Detecting differences in change
in both corneal disease and visual acuity may also require a longer
follow-up period than the 2 y in this study.
Overall, the data from this trial and earlier nonrandomised
studies suggest that, for people with minor trichiasis, repeated
epilation is associated with visual acuity and corneal change
outcomes that are comparable to surgery over a 2-y period
[4,18,21]. Where surgery is available and patients are willing to
accept it, surgery should be performed, as the disease tends to
progress, albeit quite slowly. However, we suggest that for
individuals with minor trichiasis (who represent about half of all
those with TT) epilation should be considered where surgery is
either not available or declined by the patient.
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Editors’ Summary
Background. About 40 million people are affected at any
one time by active trachoma, an infectious eye disease
caused by the bacterium Chlamydia trachomatis. Trachoma,
which is responsible for more than 3% of the world’s
blindness, mostly affects people living in rural areas in
developing countries where there are water shortages, poor
personal hygiene, and crowded living conditions. C.
trachomatis is spread through contact with infected eye
secretions or with contaminated towels or clothes, and by
flies. Recurrent infections with C. trachomatis during
childhood cause inflammation of the lining of the eye lid
(chronic conjunctival inflammation), which can lead to
conjunctival scarring. If this scarring is severe, the eyelids
turn inwards and the eye lashes rub across the eye’s surface
(the cornea). This condition—trachomatous trichiasis—is
extremely painful. Patients describe the pain like having
thorns scraping their eyes when they blink. If left untreated,
trichiasis can lead to irreversible corneal opacities and visual
impairment.
Why Was This Study Done? The SAFE strategy—surgery
for trichiasis, antibiotics for infection, and facial cleanliness
and environmental improvements to reduce transmission—
aims to control trachoma in countries where it is common.
Unfortunately, current surgical activity is only keeping up
with new cases of trichiasis; it is not clearing the backlog. The
reasons for this treatment gap are complex but in many
regions surgical provision is inadequate. Moreover, although
the World Health Organization recommends surgery for all
cases of trachomatous trichiasis, people with minor trichiasis
(only a few eyelashes touching the cornea) often decline
surgery, preferring to pull out their eyelashes (epilation), an
intervention that has to be repeated when the eyelashes
regrow. In this randomized, noninferiority trial, the
researchers compare epilation and surgery for the
management of minor trichiasis in Ethiopia, the country
with the most cases of trachomatous trichiasis. In a
randomized trial, randomly chosen groups of patients are
given different treatments for a disease and then followed to
compare the outcomes of these interventions. A
noninferiority trial investigates whether one treatment is
not worse than another treatment.
What Did the Researchers Do and Find? The researchers
randomly assigned 1,300 Ethiopians with minor trichiasis to
receive surgery or to be given epilation training and good
quality epilation forceps. The primary trial outcome was
‘‘failure’’—five or more lashes touching the eye or receiving
trichiasis surgery during the 24-month follow-up period. The
researchers decided in advance that epilation would be
deemed noninferior to surgery if its failure rate was less than
10% greater than that of surgery (a noninferiority margin of
10%). Secondary outcomes included the number of lashes
touching the eye and changes in visual acuity and corneal
opacity. The cumulative risk of failure over 24 months was
13.2% in the epilation group and 2.2% in the surgical group,
a difference of 11%. The 95% confidence interval for this
difference was 8.1%–13.9%. That is, there was a 95%
probability that the true failure rate lay within this range.
The mean number of lashes touching the eye at 24 months
was 0.95 and 0.09 in the epilation and surgery groups,
respectively, a significant difference (that is, a difference
unlikely to have occurred by chance). Finally, the changes in
visual acuity or corneal opacity during the trial were similar
in the two groups.
What Do These Findings Mean? Because the 95%
confidence interval for the difference in failure rate of the
two interventions included the preset inferiority margin,
these findings provide no evidence that epilation is
noninferior to surgery for the management of minor
trichiasis. That is, statistically speaking, this trial is
inconclusive. Thus, if one were to consider only the
primary clinical outcome when deciding whether to
include epilation in the management of mild trichiasis, one
would reject it because this trial indicates that surgery is
better than epilation at preventing lashes touching the eye.
However, epilation had a comparable effect to surgery on
visual acuity and corneal opacity changes and, importantly,
in real life, surgical services are likely to remain unacceptable,
unavailable, inaccessible, or prohibitively expensive for many
people with trachomatous trichiasis in the medium term. The
researchers suggest, therefore, that surgery should be
performed for minor trachomatous trichiasis whenever
possible but that epilation should be considered when
surgery is not available or is declined by the patient.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/
10.1371/journal.pmed.1001136.
N An accompanying PLoS Medicine Research Article by Saul
Rajak et al. describes another randomized trial undertaken
by these researchers that compares the use of absorbable
and silk sutures for the surgical treatment of trachomatous
trichiasis in Ethiopia
N The World Health Organization has information on
trachoma (in several languages), including details of the
Alliance for Global Elimination of Trachoma by the year
2020 (GET 2020) and a personal story about blinding
trachoma
N The UK National Health Service Choices web site also
provides information on trachoma
N Orbis, an international nonprofit organization devoted to
blindness prevention and treatment in developing coun-
tries, provides information about trachoma
N The International Trachoma Initiative provides detailed
personal story about trichiasis surgery in Ethiopia
information about trachoma and a personal story about
trichiasis surgery in Ethiopia
N The Global Atlas of Trachoma is an open-access resource
on the geographical distribution of trachoma
N Light for the World is a nonprofit organization dedicated to
ensuring the rights of persons with disabilities in
developing countries, including people in Ethiopia with
trachoma
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